Gd(ABE-DTTA), a novel contrast agent, at the MRI-effective dose shows absence of deleterious physiological effects in dogs.

Ruzsics, Balázs; Surányi, Pál; Kiss, Pál; Brott, Brigitta C; Elgavish, Ada; Saab-Ismail, Nada H; Simor, Tamás; Elgavish, Gabriel A

Ruzsics, Balázs; Surányi, Pál; Kiss, Pál; Brott, Brigitta C; Elgavish, Ada; Saab-Ismail, Nada H; Simor, Tamás; Elgavish, Gabriel A.

Affiliation

Ruzsics B; Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294-0005, USA.

Pharmacology ; 77(4): 188-94, 2006.

Article in En | MEDLINE | ID: mdl-16877874

Subject(s)

Contrast Media/pharmacology; Magnetic Resonance Imaging/methods; Organometallic Compounds/pharmacology; Alanine Transaminase/blood; Amylases/blood; Amylases/metabolism; Anesthetics, Inhalation/administration & dosage; Animals; Blood Proteins/analysis; Blood Proteins/metabolism; Contrast Media/chemistry; Contrast Media/toxicity; Dogs; Drug Evaluation, Preclinical/methods; Electrolytes/blood; Erythrocyte Count; Isoflurane/administration & dosage; Kidney Function Tests/methods; Leukocyte Count; Liver Function Tests/methods; Male; Molecular Structure; Myocardial Ischemia/chemically induced; Myocardial Ischemia/diagnosis; Organometallic Compounds/blood; Organometallic Compounds/chemistry; Pentetic Acid/blood; Pentetic Acid/chemistry; Pentetic Acid/pharmacology; Time Factors

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Organometallic Compounds / Magnetic Resonance Imaging / Contrast Media Type of study: Diagnostic_studies Language: En Journal: Pharmacology Year: 2006 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links